Excelsior Biopharma Net Asset Quality Index
Excelsior Biopharma net asset quality index. Excelsior Biopharma (6496) has a Net Asset Quality Index of 48.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.42 Billion minus total liabilities of NT$728.80 Million yields net assets of NT$688.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Excelsior Biopharma for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Excelsior Biopharma (2017–2025)
Net asset quality index of Excelsior Biopharma from 2017 to 2025. This chart shows how Excelsior Biopharma's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 48.6%, representing net assets of NT$688.99 Million against total assets of NT$1.42 Billion TWD. Check 6496 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Excelsior Biopharma Net Asset Quality Index by Year (2017–2025)
Excelsior Biopharma net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Excelsior Biopharma from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 6496 market cap.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.2% | NT$804.23 Million | NT$1.48 Billion | NT$679.78 Million | ▼ -8.6 pp |
| 2024 | 62.8% | NT$991.45 Million | NT$1.58 Billion | NT$586.89 Million | ▼ -7.2 pp |
| 2023 | 70.0% | NT$1.10 Billion | NT$1.58 Billion | NT$472.87 Million | ▼ -0.4 pp |
| 2022 | 70.4% | NT$1.21 Billion | NT$1.71 Billion | NT$507.53 Million | ▲ +3.5 pp |
| 2021 | 66.9% | NT$1.23 Billion | NT$1.84 Billion | NT$608.90 Million | ▼ -0.6 pp |
| 2020 | 67.5% | NT$1.28 Billion | NT$1.90 Billion | NT$617.15 Million | ▼ -16.2 pp |
| 2019 | 83.7% | NT$1.25 Billion | NT$1.50 Billion | NT$244.06 Million | ▲ +0.2 pp |
| 2018 | 83.5% | NT$1.37 Billion | NT$1.64 Billion | NT$270.88 Million | ▲ +3.7 pp |
| 2017 | 79.8% | NT$1.34 Billion | NT$1.68 Billion | NT$339.37 Million | — |